Assembly Biosciences Files 8-K

Ticker: ASMB · Form: 8-K · Filed: Feb 20, 2025 · CIK: 1426800

Assembly Biosciences, INC. 8-K Filing Summary
FieldDetail
CompanyAssembly Biosciences, INC. (ASMB)
Form Type8-K
Filed DateFeb 20, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: 8-K, regulatory-filing

Related Tickers: ASMB

TL;DR

ASMB filed an 8-K, but it's light on details for now.

AI Summary

Assembly Biosciences, Inc. filed an 8-K on February 20, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The filing does not contain specific financial figures or details about the "Other Events" beyond its classification.

Why It Matters

This 8-K filing indicates that Assembly Biosciences has made a regulatory submission, but it lacks specific details on the nature of the events or financial information disclosed.

Risk Assessment

Risk Level: low — The filing is a standard 8-K report and does not contain information that immediately suggests significant risk or opportunity.

Key Players & Entities

FAQ

What specific "Other Events" are being reported by Assembly Biosciences, Inc. in this 8-K filing?

The filing does not specify the nature of the 'Other Events' beyond its classification as such.

When was this 8-K filing submitted to the SEC?

The filing was submitted on February 20, 2025.

What is the principal business address of Assembly Biosciences, Inc.?

The principal executive offices are located at Two Tower Place, 7th Floor, South San Francisco, California 94080.

What is the Commission File Number for Assembly Biosciences, Inc.?

The Commission File Number is 001-35005.

Does this 8-K filing provide any updated financial statements or exhibits?

The filing lists 'Financial Statements and Exhibits' as an item, but the content of these is not detailed within the provided text.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on February 20, 2025 regarding ASSEMBLY BIOSCIENCES, INC. (ASMB).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing